Skip to content
Abierto
Menu

Justification, first published as presolicitation

Antidote Treatment Nerve Agent Auto-Injector (ATNAA)

SPE2DP-23-R-0002

Defense Logistics Agency, DLA Troop Support. Biological Product (except Diagnostic) Manufacturing.

View on SAM.govMarkdown

Awarded

Meridian Medical Technologies, LLC

$0.00 obligated so far on USAspending, December 5, 2025, contract SPE2DP-26-D-0001

Description

As published on SAM.gov.

In accordance with FAR 6.305(a), please see attachment for the redacted justification and approval for contract award to Meridian Medical Technologies, LLC for the manufacture and delivery of ATNAA.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Meridian Medical Technologies, LLC
UEI
VBM4PLZ9VBC4
CAGE
54452
Vendor location
Saint Louis, MO
Contract
SPE2DP26D0001
Obligated
$0.00, potential $226,440,000
Actions
1 between December 5, 2025 and December 5, 2025
Competition
Not Available for Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
4610128225!
Match
award number SPE2DP26D0001 equals the contract number; same awarding office SPE2DP (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 20, 2024

    Presolicitation

    Due April 4, 2024 at 11:59 PM EDT. SAM.gov, notice 1386d45a99284d7598469256199427fa

  2. April 12, 2024

    Presolicitation

    Due April 4, 2024 at 11:59 PM EDT. SAM.gov, notice e5558d14fe9747d39f798f3e83f504f3

  3. December 10, 2025

    Justification, originally presolicitation

    SAM.gov, notice c998e94e8f494ee1b6a68869124de624

Points of contact

Also open from this buyer